Check out the latest neurology podcast where Dr. Warnke from the Univ. of Cologne joins me to update neurologists on the need-to-know regarding JC virus infection and what’s on the horizon! ⁦Neurology Journal⁩ podcasts.apple.com/us/podcast/neu…

New research from Dr. Helen Tremlett's lab finds increased prevalence (but not incidence) of pediatric-onset #MultipleSclerosis in Canadian youth. Patient-partner Sharon Roman (n of 1) provides a simplified explanation in her blog: …ettsmsresearchexplained.wordpress.com/2023/09/23/the…

Congratulations to Edwin S.H. Leong Centre for Healthy Aging Investigator Dr. Hellen Tremlett, who's research group recently published results of a study in Neurology that found that psychiatric conditions may be a common feature of the #MultipleSclerosis #prodrome Helen Tremlett

Optical coherence tomography #OCT is increasingly a key routine diagnostic tool in neurology #MS #NMOSD #MOGAD! Thanks @ Benny Knier for coordinating this important work to ensure #OCT_Angiography quality! Thx to for letting us contribute & to #IMSVISUAL nn.neurology.org/content/10/6/e…

📣NEW study from the Tremlett Lab on the relationship between immigration, socioeconomic status & use of an #MS disease modifying drug (DMD). Odds of filling a DMD prescription ⬇️ in immigrants of ⬇️SES. It’s explained ⤵️. Pamela Kanellis Jonas Graf …ettsmsresearchexplained.wordpress.com/2023/12/04/mul…

New article alert Scientific Reports! Overall use of a first DMD to treat #MS within 5 years after the first MS-related encounter was associated with immigration status. nature.com/articles/s4159…

Accept all #cookies! Happy holidays! Thanks Heinrich-Heine-Universität Düsseldorf

#ICYMI Evidence has accumulated suggesting viruses like EBV play a role in developing MS. New study found the risk of getting #MS is lower in people living with #HIV, & using antiretroviral therapy. Is it HIV or ART? It’s explained in plain language⬇️ …ettsmsresearchexplained.wordpress.com/2023/12/15/ris…

Thrilled to announce that my DFG public | @[email protected] Research Fellowship project has been published The Lancet Reg Health-Americas: Disease-modifying drugs, #MS and infection-related healthcare use in British Columbia, Canada: a population-based study. thelancet.com/journals/lanam…

Class III evidence that for patients with #MS, while disease-modifying drug (DMD) exposure reduces the risk of infection-related hospitalizations, there are increased risks of infection-related physician visits and incident adverse events for select DMDs: bit.ly/3TUrF84

First issue of 2024 is out now!!! Click to read on thelancet.com/journals/lanam… 🦠Bocavirus #respiratoryinfection 🐍Antivenom for #snakebite 🧏Tinitus incidence in US and much more +++

Extremely rare, but a key priority neuroimmunology-munich.de! It's about cryopyrin-associated periodic syndromes (#CAPS) with CNS involvement 🧠 Overall, our study shows that #OCT 👁️‍🗨️ can be used as a marker of systemic inflammation! Dx and monitoring! onlinelibrary.wiley.com/doi/10.1111/en…

📢Recent study reviewed what is known about the early signs & symptoms of demyelinating disorders (#MS, NMOSD & MOGAD), & compared to what is known about 3 neurodegenerative disorders (ALS, AD & PD). How do the early signs & symptoms compare? Easy read👇🏽 …ettsmsresearchexplained.wordpress.com/2024/06/04/pro…

From @JAMA_Current: Special Communication examines drawing causal inferences about the effects of interventions from observational studies in medical journals and suggests a framework that might be used. ja.ma/4ccyVCp

Early Maintenance Treatment Initiation and Relapse Risk Mitigation After a First Event of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease in Adults: The MOGADOR2 Study bit.ly/4f2pEz3

Excited to share our newest study published Frontiers - Immunology on the relevance of #heterophoria in #MS patients! Check it out: frontiersin.org/journals/immun…

“MS may start some years before the clinical onset," says Prof. Helen Tremlett of University of British Columbia. Understanding #MS #prodrome could be key to improving early diagnosis and treatment, or even to stop the condition. Read our latest Insights to learn more: bit.ly/3WRKfh5

📢 NEW study of the population of Germany (~60,000,000 people) provides a much-needed update on the rate of new #MS cases (incidence) & the ratio of females to males with new onset MS from 2015-2022. Have new cases of MS ⬆️ or ⬇️? 👇🏽in plain language. …ettsmsresearchexplained.wordpress.com/2024/09/10/upd…

Did covid-19 make multiple sclerosis more common? Probably not. The incidence in Germany is stable between 2015 and 2022 jamanetwork.com/journals/jaman…